Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.7%, driven by Trajan Group Holdings declining 5.9%. Overall the industry is down 13% in 12 months. Looking forward, earnings are forecast to grow by 74% annually.
Has the Australian Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 02 May 2024 | AU$540.3m | AU$246.1m | -AU$49,506,434.00 | 18.4x | -10.9x | 2.2x |
Sat, 30 Mar 2024 | AU$539.1m | AU$246.1m | -AU$49,506,434.00 | 14.3x | -10.9x | 2.2x |
Mon, 26 Feb 2024 | AU$505.1m | AU$243.2m | -AU$44,302,241.00 | 19.5x | -11.4x | 2.1x |
Wed, 24 Jan 2024 | AU$458.8m | AU$248.2m | -AU$39,797,313.00 | 25.8x | -11.5x | 1.8x |
Fri, 22 Dec 2023 | AU$529.2m | AU$248.6m | -AU$52,451,569.00 | 21.8x | -10.1x | 2.1x |
Sun, 19 Nov 2023 | AU$543.8m | AU$248.6m | -AU$52,451,569.00 | 22.3x | -10.4x | 2.2x |
Tue, 17 Oct 2023 | AU$559.1m | AU$248.6m | -AU$52,451,569.00 | 22.3x | -10.7x | 2.2x |
Thu, 14 Sep 2023 | AU$570.6m | AU$248.6m | -AU$52,451,569.00 | 22.7x | -10.9x | 2.3x |
Sat, 12 Aug 2023 | AU$645.3m | AU$221.5m | -AU$37,611,177.00 | 25.2x | -17.2x | 2.9x |
Mon, 10 Jul 2023 | AU$653.0m | AU$221.5m | -AU$37,611,177.00 | 25.2x | -17.4x | 2.9x |
Wed, 07 Jun 2023 | AU$663.9m | AU$221.5m | -AU$37,611,177.00 | 21.5x | -17.7x | 3x |
Fri, 05 May 2023 | AU$618.2m | AU$221.5m | -AU$37,611,177.00 | 28.3x | -16.4x | 2.8x |
Sun, 02 Apr 2023 | AU$722.0m | AU$221.7m | -AU$39,169,534.00 | 30.2x | -18.4x | 3.3x |
Tue, 28 Feb 2023 | AU$781.1m | AU$174.6m | -AU$40,998,286.00 | 30.2x | -19.1x | 4.5x |
Thu, 26 Jan 2023 | AU$812.7m | AU$184.6m | -AU$29,264,632.00 | 36.6x | -27.8x | 4.4x |
Sat, 24 Dec 2022 | AU$776.6m | AU$184.6m | -AU$29,264,632.00 | 33.6x | -26.5x | 4.2x |
Mon, 21 Nov 2022 | AU$761.0m | AU$184.6m | -AU$29,264,632.00 | 30.3x | -26x | 4.1x |
Wed, 19 Oct 2022 | AU$783.2m | AU$184.6m | -AU$29,264,632.00 | 30.4x | -26.8x | 4.2x |
Fri, 16 Sep 2022 | AU$852.9m | AU$184.6m | -AU$29,264,632.00 | 35.6x | -29.1x | 4.6x |
Sun, 14 Aug 2022 | AU$961.2m | AU$150.4m | -AU$31,222,532.00 | 28.2x | -30.8x | 6.4x |
Tue, 12 Jul 2022 | AU$882.3m | AU$150.4m | -AU$31,222,532.00 | 26.5x | -28.3x | 5.9x |
Thu, 09 Jun 2022 | AU$956.2m | AU$150.4m | -AU$31,222,532.00 | 28.9x | -30.6x | 6.4x |
Sat, 07 May 2022 | AU$1.1b | AU$150.2m | -AU$30,481,316.00 | 26.1x | -36.2x | 7.4x |
Mon, 04 Apr 2022 | AU$1.2b | AU$167.1m | -AU$90,069,489.00 | 19.9x | -13.3x | 7.2x |
Wed, 02 Mar 2022 | AU$1.4b | AU$164.2m | -AU$90,069,489.00 | 19.1x | -15x | 8.2x |
Fri, 28 Jan 2022 | AU$1.7b | AU$138.2m | -AU$84,243,063.00 | 108.5x | -19.8x | 12x |
Sun, 26 Dec 2021 | AU$1.5b | AU$138.2m | -AU$84,243,063.00 | 120.6x | -18.2x | 11.1x |
Tue, 23 Nov 2021 | AU$1.4b | AU$138.2m | -AU$84,243,063.00 | 108x | -17x | 10.4x |
Thu, 21 Oct 2021 | AU$1.5b | AU$138.2m | -AU$84,243,063.00 | 120.2x | -17.2x | 10.5x |
Sat, 18 Sep 2021 | AU$1.6b | AU$138.2m | -AU$84,243,063.00 | 133.7x | -19x | 11.6x |
Mon, 16 Aug 2021 | AU$1.4b | AU$148.9m | -AU$96,965,525.00 | 83.4x | -14.4x | 9.4x |
Mon, 31 May 2021 | AU$1.3b | AU$78.7m | -AU$82,853,575.00 | 38.9x | -15.8x | 16.6x |
-18.5x
How does Australian Clinical Research and Equipment compare with similar industries?
AU Market | -1.54% | |
Healthcare | -1.12% | |
Life Sciences | -2.71% | |
Clinical Research and Equipment | -2.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
GSS Genetic Signatures | AU$0.70 | 3.7% +AU$4.7m | 2.2% | PS8.2x | |
GTG Genetic Technologies | AU$0.12 | 4.3% +AU$661.1k | -40.0% | PS1.5x |